Pharmaceutical

With Pfizer discontinuing Beqvez and BioMarin scaling back the commercial focus of Roctavian, the curative promise of hemophilia gene therapies is tem...

It was another swing and a miss for the biopharma industry on Thursday, when a federal appeals court in Philadelphia unanimously rejected (PDF) a chal...

While Gilead Sciences previously ponied up hundreds of millions of dollars to resolve kickback allegations related to its HIV business, the company th...

Mikhail Varshavski, D.O., more widely known as Doctor Mike to his 29 million followers, noticed eight years ago the growing influence of online conten...

Amid the Trump administration’s call for a crackdown on direct-to-consumer pharmaceutical advertising, a new survey shows that many people with chroni...

As Robert F. Kennedy Jr.’s revamped Centers for Disease Control and Prevention (CDC) vaccine advisory panel gears up to meet next week, U.S. health of...

James Potter, the executive director at Coalition for Healthcare Communication (CHC), has rose-colored glasses on. Both literally and figuratively: Th...

What could GLP-1 drugs, known for their powerful weight loss benefits, have to do with oncology? Potentially “everything,” according to Deborah Phippa...

Today, a brief rundown of news involving Takeda Pharmaceutical and Maze Therapeutics, as well as updates from Intercept Pharmaceuticals, Soleno Therap...

Merck presents phase 3 STRIDE-13 trial results at ESCMID conference in Lisbon Merck presents phase 3 STRIDE-13 trial results at ESCMID conference in L...